Response to D.M. Marcus's comment on the TRIFRA study (comparison of Tripterygium wilfordii Hook F vs methotrexate in the treatment of active rheumatoid arthritis)

Ann Rheum Dis. 2014 Sep;73(9):e57. doi: 10.1136/annrheumdis-2014-205973.

Authors

Qian-Wen Lv¹, Wen Zhang¹, Qun Shi¹, Wen-Jie Zheng¹, Peter E Lipsky², Xuan Zhang¹

Affiliations

¹ Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Formerly National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.

PMID: 25085980
DOI: 10.1136/annrheumdis-2014-205973

No abstract available

Keywords: Methotrexate; Rheumatoid Arthritis; Treatment.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Humans
Methotrexate / therapeutic use*
Phytotherapy / adverse effects*
Tripterygium / adverse effects*

Substances

Antirheumatic Agents
Methotrexate